Search results
Weight-loss injections could halve risk of cancer
The Telegraph via Yahoo News· 2 days agoA study of 75 women with breast cancer by researchers from the Memorial Sloan Kettering Cancer Centre in New York ...
Scientists develop AI tool to predict how cancer patients will respond to immunotherapy
Medical Xpress· 3 days agoNCI is part of the National Institutes of Health. Currently, two predictive biomarkers are approved by the Food and Drug ...
Docs Endorsing Products on X May Not Disclose Company Ties
Medscape· 2 hours agoLead author Aaron Mitchell, MD, MPH, a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City ...
Immunotherapy bowel cancer drug works for 100% of patients
dpa international via Yahoo News· 3 days agoAn immunotherapy drug could spare bowel cancer patients the need for surgery after results showed it...
NIH, MSKCC researchers publish AI model for predicting immunotherapy responses
FierceBiotech· 2 days agoResearchers at the National Institutes of Health and Memorial Sloan Kettering Cancer Center said...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 6 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
GSK reports 100% response in rectal cancer study with Jemperli By Investing.com
Investing.com· 3 days agoGSK plc (LSE/NYSE: LON:GSK) has shared updated results from a phase II study conducted in...
New bowel tumor drug helped cure cancer in 100% of cases
BGR· 2 days agoA drug called Jemperli (dostarlimab) showed impressive results in a phase 2 trial at the Memorial ...
Newswise Expert | Yuanyuan Zhang, UT Southwestern Medical Center
Newswise· 1 day agoDr. Zhang earned her medical and doctorate degrees from UT Southwestern. Following graduation, she completed an internship with Memorial Sloan-Kettering ...
GSK’s Jemperli shows potential in Phase II trial for locally advanced rectal cancer
Clinical Trials Arena via Yahoo Finance· 2 days agoThe drug candidate was found to be 100% effective in treating all patients who were enrolled in the...